Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is This The End Of Illumina’s Great Run?
Forbes
Friday, August 5, 2011 - 1:52pm
tags:
Illumina
Forest Labs Says Regulators Considered U.S. Business Ban on 8 Executives
Bloomberg
Friday, August 5, 2011 - 1:51pm
tags:
pharmaceutical executives, Forest Labs, Carl Icahn
Sequenom pares 2nd-quarter loss by more than half; revenue rises 17 percent
Yahoo/AP
Friday, August 5, 2011 - 1:23pm
tags:
earnings, Sequenom
Biosimilars: US payers "will want more data than FDA"
Pharma Times, UK
Friday, August 5, 2011 - 1:19pm
tags:
biosimilars, FDA
Amylin, Takeda call off obesity treatment
Bloomberg/Businessweek
Friday, August 5, 2011 - 1:17pm
tags:
Takeda, pramlintide/metreleptin, obesity, Amylin
Alere to Make 230 Million-Pound Hostile Bid for Axis-Shield
Bloomberg
Friday, August 5, 2011 - 11:48am
tags:
Alere, Axis-Shield, hostile bid, M&A, diagnostics
Novartis’s Jimenez Has Blockbuster Plans for Diovan After Patent Expires
Bloomberg
Friday, August 5, 2011 - 11:46am
tags:
Diovan, Novartis, Joe Jimenez
Here's Why Teva's Latest Report Might Worry You
Motley Fool
Friday, August 5, 2011 - 10:23am
tags:
Teva Pharmaceuticals
Momenta Pharmaceuticals - Earnings
Yahoo/InvestorsBusinessDaily
Friday, August 5, 2011 - 10:22am
tags:
Momenta, earnings
Somaxon's Bore of a Quarter
Motley Fool
Friday, August 5, 2011 - 10:13am
tags:
Somaxon, earnings
How Many Doctors Won’t Accept Samples?
Pharmalot
Friday, August 5, 2011 - 10:10am
tags:
physicians, samples
Merck cuts put pharma on top of layoffs list
Fierce Pharma
Thursday, August 4, 2011 - 4:59pm
tags:
layoffs, Merck
Dendreon Falls Most Ever After Pulling Sales Forecast on Cancer Therapy
Bloomberg
Thursday, August 4, 2011 - 4:36pm
tags:
Provenge, Dendreon, prostate cancer
Endo Pharmaceuticals Earnings Preview
Motley Fool
Thursday, August 4, 2011 - 4:35pm
tags:
Endo, earnings
Dendreon CEO Dumped $1M in Stock Before Withdrawing Revenue Guidance
BNET Pharma
Thursday, August 4, 2011 - 1:09pm
tags:
Dendreon, Provenge, Pharma CEOs, Mitchell Gold
Vanda Pharmaceuticals reports loss
Bizjournals.com
Thursday, August 4, 2011 - 1:06pm
tags:
earnings, Vanda
Multitalented Botox could get $500M off bladder indication
Fierce Pharma
Thursday, August 4, 2011 - 10:59am
tags:
Botox, Allergan, overactive bladder
Dendreon's Blowup Spreads Across Biotech
TheStreet.com
Thursday, August 4, 2011 - 10:57am
tags:
Dendreon, Provenge, InterMune, Human Genome Sciences, Seattle Genetics, Regeneron, Savient
YM BioSciences JAK Inhibitor CYT387 Shown Active in Multiple Myeloma
Yahoo
Thursday, August 4, 2011 - 10:56am
tags:
JAK inhibitors, CYT387, Multiple Myeloma, YM BioSciences
MAP Pharmaceuticals Reports Second Quarter of 2011 Financial Results
Yahoo
Thursday, August 4, 2011 - 10:26am
tags:
MAP Pharmaceuticals, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.